DNA vaccine therapy for chronic hepatitis C virus (HCV) infection: immune control of a moving target

Human occludin is a hepatitis C virus entry factor required for infection of mouse cells

(2009) Alexander Ploss et al.   NATURE

Therapeutic Vaccination of Chronic Hepatitis C Nonresponder Patients With the Peptide Vaccine IC41

(2008) Christoph S. Klade et al.   GASTROENTEROLOGY

Cleavage of the IPS-1/Cardif/MAVS/VISA does not inhibit T cell-mediated elimination of hepatitis C virus non-structural 3/4A-expressing hepatocytes

(2008) G Ahlen et al.   GUT

Occult hepatitis C: How convincing are the current data?

(2008) Martin-Walter Welker et al.   HEPATOLOGY

Immunogenicity of CIGB-230, a therapeutic DNA vaccine preparation, in HCV-chronically infected individuals in a Phase I clinical trial

(2008) L. Alvarez-Lajonchere et al.   JOURNAL OF VIRAL HEPATITIS

DNA vaccines: ready for prime time?

(2008) Michele A. Kutzler et al.   NATURE REVIEWS GENETICS